Samsara BioCapital, L.P. — Form D/A
Samsara BioCapital, L.P. of PALO ALTO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2018-04-20. The offering totals $310.1M, of which $310.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-04-20
- Form: D/A
- Accession: 0001699737-18-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $310.1M
- Amount sold: $310.1M
- Investors: 57
- Date of first sale: 2017-03-22
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-283028
Issuer
- Name: Samsara BioCapital, L.P.
- CIK: 0001699737
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 628 MIDDLEFIELD ROAD, PALO ALTO, CA, 94301
- Phone: (650) 285-4270
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Srinivas NA Akkaraju | Director | Palo Alto, CA |
| Michael NA Dybbs | Director | Palo Alto, CA |
| N/A NA Samsara BioCapital GP, LLC | Director | Palo Alto, CA |
| Michael Dybbs | Director | Half Moon Bay, CA |
| Srinivas Akkaraju | Director | Palo Alto, CA |
| N/A SAMSARA BIOCAPITAL GP, LLC | Director | Palo Alto, CA |
Other filings by this issuer (3)
More